Becton Dickinson vs Boston Scientific
Becton Dickinson (BDX) and Boston Scientific (BSX) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $58.9B
- Last close
- $216.08
- 12 months
- +12.3%
- Market value
- $63.3B
- Last close
- $43.64
- 12 months
- −56.0%
At a glance
- Becton Dickinson and Boston Scientific are close in size by market value ($58.9B and $63.3B).
- Over the last 12 months Becton Dickinson's share price moved +12.3% and Boston Scientific's −56.0%; against the S&P 500 that is +1.7 points and −66.6 points.
- In the last 90 days insiders reported 0 open-market purchases at Becton Dickinson and 1 at Boston Scientific; members of Congress disclosed 0 trades in Becton Dickinson and 7 in Boston Scientific.
- Next results: Becton Dickinson Feb 8, 2027, Boston Scientific Feb 2, 2027.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Becton Dickinson BDXNYSE · Health Care Equipment | Boston Scientific BSXNYSE · Health Care Equipment | |
|---|---|---|
| Size and profitability | ||
| Market value | $58.9B | $63.3B |
| Revenue, last fiscal year | $21.8B | $20.1B |
| Net income, last fiscal year | $1.68B | — |
| Net marginNet income as a share of revenue | 7.7% | — |
| Free cash flow | $2.67B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Becton Dickinson against
Common questions
How is Becton Dickinson different from Boston Scientific?
Becton Dickinson (BDX) is in Health Care Equipment on NYSE, with $21.8B of revenue in its last fiscal year and a net margin of 7.7%. Boston Scientific (BSX) is in Health Care Equipment on NYSE, with $20.1B of revenue in its last fiscal year. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Becton Dickinson and Boston Scientific compare in size?
Boston Scientific has the larger market value: Becton Dickinson $58.9B and Boston Scientific $63.3B, at the last close.
Whose share price rose more over the last 12 months, BDX or BSX?
Over the last 12 months Becton Dickinson moved +12.3% and Boston Scientific −56.0%. Past price moves say nothing about the future.
Which has had more insider buying, Becton Dickinson or Boston Scientific?
Since 2006, Boston Scientific insiders reported 115 open-market purchases against 10 for Becton Dickinson. These are counts of what was filed, not a view on either stock.
Do members of Congress trade BDX or BSX?
In the last 12 months, members of Congress disclosed 3 trades in Becton Dickinson (BDX) and 23 in Boston Scientific (BSX).
When did insiders last buy BDX and BSX?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Becton Dickinson pageBoston Scientific pageRare insider trades this weekAll comparisons
https://oqro.io/compare/bdx-vs-bsx







